DALLAS, July 7, 2015 /PRNewswire/ --
According to a new market research report "Blood Culture Test Market by Method (Manual, Automated), Product (Consumables, Instrument), Application (Aerobic, Anaerobic, Yeast/ Fungi) & End User (Hospital, Reference Laboratory, Clinical Laboratory, Academic Research Institute) - Forecast to 2019", published by MarketsandMarkets, The global Blood Culture Tests Market is expected to reach $3,893.5 Million by 2019 from $2,750.2 Million in 2014 at a CAGR of 7.2% from 2014-2019.
Browse 178 market data Tables and 37 Figures spread through 250 Pages and in-depth TOC on "Blood Culture Test Market"
Early buyers will receive 10% customization on this report.
The global blood culture tests market is expected to reach $3,893.5 Million by 2019 from $2,750.2 Million in 2014 at a CAGR of 7.2% from 2014-2019.
Inquiry before Buying: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=159606753
The report segments the blood culture tests market on the basis of methods, products, applications, end users, and region. On the basis of products, the market is segmented into consumables, instruments and software and services. The consumables segment is expected to account for the largest share of the blood culture tests market, by product in 2014. The large share of this segment is attributed to the higher demand and repeated purchase of the consumables as compared to instruments. Among the end users segment, the reference laboratories segment is expected to grow at a highest CAGR during the forecast period. Demand for the rapid diagnostic techniques and identification of antibiotic resistant microorganisms are some of the factors that will drive the growth of this segment. Factors such as high incidence of Blood Stream Infections (BSI) increase in demand for the rapid diagnostic techniques, high prevalence of infectious diseases, rapidly growing aging population, and technological advancements are major factors propelling the growth of this segment. On the other hand, high cost of automated instruments and stringent regulatory approval process are the factors which are likely to hinder the growth of the market. A number of factors such as high growth opportunities in emerging economies and need to identify antibiotic resistant microorganisms are expected to create an array of opportunities for the blood culture tests market.
On the basis of region, the blood culture test market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America accounted for the largest share of this market in 2014, while Asia is likely to witness the highest growth in this market from 2014-2019. The high growth of this region is attributed to the large population base, geriatric population base especially in Japan, government initiatives to increase awareness about sepsis, and growing regulatory approvals for blood culture tests in this region.
Key market players in the blood culture market include bioMérieux SA (France), Becton, Dickinson and company (U.S.), Cepheid, Inc. (U.S.), Nanosphere, Inc. (U.S.), Bruker Corporation (U.S.), Alere, Inc. (U.S.), Beckman Coulter, Inc. (U.S.), IRIDICA (subsidiary of Abbott Laboratories) (U.S.), and Roche Diagnostics (Switzerland).
Browse Related Reports:
Blood Screening Market by Technology (Nucleic Acid Amplification Test, ELISA, Rapid Test, Chemiluminescence Immunoassay, Next Generation Sequencing, Western Blotting), Product (Instrument, Reagent) & End User (Blood Bank, Hospital) - Forecasts to 2019
Infectious Disease Diagnostics Market by Product (Instruments, Reagents, Services, Software), Application (Hepatitis C, AIDS, Tuberculosis), Technology (PCR, INAAT, DNA Sequencing, Hybridization), End User (Hospital, Laboratories) - Global Forecast to 2019
MarketsandMarkets is world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/medical-devices
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets